Article

Efficacy and safety of PARP inhibitors in the treatment of BRCA-mutated breast cancer: An updated systematic review and meta-analysis of randomized controlled trials

2022-09-22

Abstract excerpt

<h4>Aims: </h4>: Poly-ADP-ribose polymerase inhibitors have emerged as a new class of therapeutic agents for breast cancer patients with BRCA mutations; however, the efficacy and toxicity of PARP inhibitors have not been clearly established. <h4>Methods:</h4> This study comprehensively evaluated the efficacy and safety of PARP inhibitors in BRCA mutated breast cancer patients. Online databases were systematically...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 79258483-2c84-5771-b6de-73f47d76eccf
DOI: 10.22541/au.166385163.37355039/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Efficacy and safety of PARP inhibitors in the treatment of BRCA-mutated breast cancer: An updated systematic review and meta-analysis of randomized controlled trialsDOI 10.22541/au.166385163.37355039/v1Read

Efficacy and safety of PARP inhibitors in the treatment of BRCA-mutated breast cancer: An updated systematic review and meta-analysis of randomized controlled trialsSemantic proximity Read

PARP inhibitors in the management of breast cancer: current data and future prospects.Semantic proximity Read

Deep exploration of PARP inhibitors in breast cancer: monotherapy and combination therapy.Semantic proximity Read

Efficacy and Safety of BRCA-targeted Therapy (Polyadenosine Diphosphate-ribose Polymerase Inhibitors) in Treatment of BRCA-mutated Breast Cancer: A Systematic Review and Meta-analysis.Semantic proximity Read

Therapeutic advances and application of PARP inhibitors in breast cancerSemantic proximity Read

PARP inhibitor treatment of advanced breast cancer beyond the BRCA-mutated type: a meta-analysis.Semantic proximity Read

Advances in PARP inhibitors for the treatment of breast cancer.Semantic proximity Read

PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor ResistanceSemantic proximity Read

Mechanisms of PARP-Inhibitor-Resistance in BRCA-Mutated Breast Cancer and New Therapeutic ApproachesSemantic proximity Read

PARP inhibitors in breast and ovarian cancer with BRCA mutations: a meta-analysis of survival.Semantic proximity Read

Role of PARP in TNBC: Mechanism of Inhibition, Clinical Applications, and ResistanceSemantic proximity Read

PARP inhibitors: a tsunami of indications in different malignancies.Semantic proximity Read